Editas Medicine, Inc. (EDIT)

2.40 -0.09 (-3.61%) USD  |  NASDAQ  |  Oct 23, 16:00
2.385 -0.02 (-0.62%) Pre-Market: 20:00
More

Editas Medicine Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
Date Value
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Geron Corp. Upgrade
Halozyme Therapeutics, Inc. Upgrade
Novavax, Inc. Upgrade